Oregon Public Employees Retirement Fund Biogen Inc. Transaction History

Oregon Public Employees Retirement Fund

$4.78 Billion
Q1 2024

A detailed history of Oregon Public Employees Retirement Fund transactions in Biogen Inc. stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 12,396 shares of BIIB stock, worth $2.78 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

12,396

Previous 11,337 9.34%

Holding current value

$2.78 Million

Previous $2.93 Million 8.9%

% of portfolio

0.06%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$212.02 - $267.71 $224,529 - $283,504	1,059 Added 9.34%	12,396 $2.67 Million
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $2.07 Million - $2.49 Million	-9,305 Reduced 45.08%	11,337 $2.93 Million
Q3 2023 Oct 26, 2023	SELL	$253.3 - $285.89 $1.05 Million - $1.19 Million	-4,162 Reduced 16.78%	20,642 $5.31 Million
Q2 2023 Jul 26, 2023	SELL	$275.25 - $318.06 $6.04 Million - $6.97 Million	-21,926 Reduced 46.92%	24,804 $7.07 Million
Q1 2023 May 04, 2023	SELL	$256.56 - $292.34 $208,070 - $237,087	-811 Reduced 1.71%	46,730 $13 Million

Q4 2022 Jan 26, 2023	BUY	$252.44 - $306.72 $4.43 Million - $5.38 Million	17,546 Added 58.5%	47,541 $0
Q3 2022 Nov 01, 2022	SELL	$194.69 - $268.46 $139,787 - $192,754	-718 Reduced 2.34%	29,995 $8.01 Million
Q2 2022 Jul 25, 2022	SELL	$187.54 - $223.02 $3.55 Million - $4.22 Million	-18,910 Reduced 38.11%	30,713 $6.26 Million
Q1 2022 Apr 21, 2022	SELL	$193.77 - $244.14 $658,042 - $829,099	-3,396 Reduced 6.41%	49,623 $10.5 Million
Q4 2021 Feb 01, 2022	SELL	$223.92 - $287.77 $2.33 Million - $3 Million	-10,418 Reduced 16.42%	53,019 $12.7 Million
Q3 2021 Oct 19, 2021	BUY	$282.99 - $369.05 $95,650 - $124,738	338 Added 0.54%	63,437 $18 Million
Q2 2021 Jul 23, 2021	SELL	$259.0 - $414.71 $2.94 Million - $4.71 Million	-11,368 Reduced 15.27%	63,099 $21.8 Million
Q1 2021 Apr 20, 2021	SELL	$242.95 - $284.63 $163,262 - $191,271	-672 Reduced 0.89%	74,467 $20.8 Million
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $5.73 Million - $8.63 Million	-24,266 Reduced 24.41%	75,139 $18.4 Million
Q3 2020 Nov 03, 2020	SELL	$264.77 - $305.71 $2.02 Million - $2.33 Million	-7,627 Reduced 7.13%	99,405 $28.2 Million
Q2 2020 Jul 21, 2020	SELL	$258.66 - $342.55 $4.3 Million - $5.69 Million	-16,619 Reduced 13.44%	107,032 $28.6 Million
Q1 2020 Apr 20, 2020	BUY	$268.85 - $341.04 $10.7 Million - $13.5 Million	39,720 Added 47.32%	123,651 $39.1 Million
Q4 2019 Feb 05, 2020	BUY	$220.06 - $304.07 $2 Million - $2.76 Million	9,078 Added 12.13%	83,931 $24.9 Million
Q3 2019 Nov 07, 2019	BUY	$217.44 - $243.88 $351,165 - $393,866	1,615 Added 2.21%	74,853 $17.4 Million
Q2 2019 Jul 16, 2019	BUY	$219.29 - $241.72 $5.64 Million - $6.22 Million	25,722 Added 54.13%	73,238 $17.1 Million
Q1 2019 May 07, 2019	SELL	$216.71 - $338.96 $7,584 - $11,863	-35 Reduced 0.07%	47,516 $11.2 Million
Q4 2018 Feb 07, 2019	SELL	$278.5 - $352.75 $3.97 Billion - $5.03 Billion	-14,261,496 Reduced 99.67%	47,551 $14.3 Million
Q4 2018 Feb 05, 2019	BUY	$278.5 - $352.75 $3.97 Billion - $5.03 Billion	14,257,427 Added 27619.97%	14,309,047 $48,000
Q3 2018 Oct 30, 2018	BUY	$293.51 - $383.83 $84,237 - $110,159	287 Added 0.56%	51,620 $18.2 Million
Q2 2018 Aug 13, 2018	SELL	$257.52 - $306.91 $766,122 - $913,057	-2,975 Reduced 5.48%	51,333 $14.9 Million
Q1 2018 Apr 12, 2018	BUY	$260.13 - $367.91 $119,659 - $169,238	460 Added 0.85%	54,308 $14.9 Million
Q4 2017 Jan 11, 2018	SELL	$307.64 - $344.58 $792,480 - $887,638	-2,576 Reduced 4.57%	53,848 $0
Q3 2017 Nov 02, 2017	BUY	$281.15 - $329.69 $15.9 Million - $18.6 Million	56,424	56,424 $17.7 Million

Others Institutions Holding BIIB

# of Institutions

1,047

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.3B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.

Account

Oregon Public Employees Retirement Fund Biogen Inc. Transaction History